Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas
Clinical trial NCT02828111 · COMPLETED
Trial details
- NCT number
- NCT02828111
- Sponsor
- PellePharm, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-11
- Primary completion
- 2017-11-09
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.